Drug Pipeline

Nitazoxanide Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
2
Recruiting
1
Phase 3
3
Top Sponsors
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-02 NCT04746183
AGILE (Early Phase Platform Trial for COVID-19)		 date change Primary completion pushed: 2026-07-31 -> 2027-03-31
2026-06-02 NCT04746183
AGILE (Early Phase Platform Trial for COVID-19)		 date change Completion pushed: 2026-07-31 -> 2027-03-31
Active Studies by Phase
Phase 3
1
Phase 2
1
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06600711 Nitazoxanide for Treatment of Cryptosporidium in Children Cryptosporidiosis Not Yet Recruiting
Phase 2
NCT05041907 Finding Treatments for COVID-19: A Trial of Antiviral Pharmacodynamics in Early… COVID-19 Recruiting
Phase 1/2
NCT04746183 AGILE (Early Phase Platform Trial for COVID-19) Covid19 Recruiting
Sponsors Running Nitazoxanide Trials
University of Liverpool (1) University of Oxford (1) Johns Hopkins Bloomberg School of Public Health (1)
Get alerts when Nitazoxanide trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free